These molecules render the tumor microenvironment and facilitate progression and metastatic dissemination of melanomas via autocrine and paracrine activation of CXCR1 and CXCR2 chemokine receptors (reviewed in [1]). This evidence concerns the gene CXCR1 and neoplasm.